These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37058860)

  • 1. Intravenous topiramate for seizure emergencies - First in human case report.
    Apostolakopoulou L; Bosque Varela P; Rossini F; O'Sullivan C; Löscher W; Kuchukhidze G; Trinka E
    Epilepsy Behav; 2023 May; 142():109158. PubMed ID: 37058860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of intravenous topiramate for the treatment of status epilepticus.
    Löscher W; Trinka E
    Epilepsy Behav; 2023 Jan; 138():109032. PubMed ID: 36528009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate.
    Glauser TA
    Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
    Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
    Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate in refractory epilepsy: a prospective observational study.
    Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacokinetics and tolerability of a novel meglumine-based parenteral solution of topiramate and topiramate combinations for treatment of status epilepticus.
    Rundfeldt C; Klein P; Boison D; Rotenberg A; D'Ambrosio R; Eastman C; Purnell B; Murugan M; Goodkin HP; Löscher W
    Epilepsia; 2023 Apr; 64(4):888-899. PubMed ID: 36708090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in patients with learning disability and refractory epilepsy.
    Kelly K; Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
    Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
    Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B;
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.
    Montouris GD; Biton V; Rosenfeld WE
    Epilepsia; 2000; 41(S1):77-81. PubMed ID: 10768306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E
    Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of topiramate and its clinical value in epilepsy.
    Bai YF; Zeng C; Jia M; Xiao B
    Seizure; 2022 May; 98():51-56. PubMed ID: 35421622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy.
    Latini G; Verrotti A; Manco R; Scardapane A; Del Vecchio A; Chiarelli F
    Mini Rev Med Chem; 2008 Jan; 8(1):10-23. PubMed ID: 18220981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary open-label experience with topiramate in primary generalized seizures.
    Biton V
    Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
    Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate for the treatment of juvenile myoclonic epilepsy.
    Sousa Pda S; Araújo Filho GM; Garzon E; Sakamoto AC; Yacubian EM
    Arq Neuropsiquiatr; 2005 Sep; 63(3B):733-7. PubMed ID: 16258645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.